Cargando…
The effect of topiramate on weight loss in patients with type 2 diabetes
BACKGROUND: Obesity has been associated with several co-morbidities such as diabetes and increased mortality. In general, the use of medication promotes only a modest weight loss in the range of 2 to 10 kg, usually most effective during the first 6 months of therapy; however, studies have shown posi...
Autores principales: | Moradi, Sedighe, Kerman, Scott Reza Jafarian, Mollabashi, Mina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793374/ https://www.ncbi.nlm.nih.gov/pubmed/24124426 |
Ejemplares similares
-
Association between diabetes complications and leukocyte counts in Iranian patients
por: Moradi, Sedigheh, et al.
Publicado: (2012) -
Formulary Management of 2 New Agents: Lorcaserin and Phentermine/Topiramate for Weight Loss
por: Kelly, Elizabeth M., et al.
Publicado: (2013) -
The Use of Topiramate for Weight Loss Causing Acute Glaucoma: A Case Report and Literature Review
por: DE OLIVEIRA, Bruno Mauricio Rodrigues, et al.
Publicado: (2019) -
Utilization of Topiramate as an Adjunct to Lifestyle Intervention for Weight Loss in Pediatric Nonalcoholic Fatty Liver Disease
por: Kohut, Taisa, et al.
Publicado: (2021) -
Weight Loss During Topiramate Treatment in a Severely Obese Adolescent with Congenital Adrenal Hyperplasia and Migraine
por: Seagroves, Amy, et al.
Publicado: (2023)